Aquaporin A/S Announces Last Trading Day for Pre-emptive Rights in Rights Issue

Aquaporin A/S, the innovative water technology company based in Denmark, has made a significant announcement regarding its rights issue, marking today as the last day for trading existing shares with pre-emptive rights. This trading period is critical for shareholders wishing to maintain their proportionate ownership in the company.

Key Details of the Announcement

Today, January 2, 2026, is the final opportunity for investors to buy shares that carry these important pre-emptive rights. If shares are traded after 5:00 PM CET, they will no longer include these rights, which are essential for subscribers looking to purchase new shares at the designated subscription price.

As of January 6, 2026, shareholders will receive ten (10) pre-emptive rights for each existing share they hold. The right, however, is not a guarantee; it requires careful management, as shareholders need three (3) pre-emptive rights to buy one (1) new share at a price of DKK 1.

Trading Timeline for Rights

- Trading Start: The rights trading period will start on January 5, 2026, at 9:00 AM CET.
- Trading End: It concludes on January 16, 2026, at 5:00 PM CET.

During this trading phase, any rights that existing shareholders do not utilize or sell will expire, becoming worthless if they fail to subscribe to new shares before the closing date.

Subscription Details

The subscription period for new shares will commence on January 7, 2026, and end on January 20, 2026. This is a critical window for investors who need to act promptly if they wish to secure new shares before the event concludes. Importantly, shareholders not fully exercising their rights may face dilution of their holdings, potentially up to 77%, assuming all new shares are subscribed.

Company Background

Aquaporin A/S stands at the forefront of water filtration technology, driven by a commitment to tackle global water challenges. Utilizing its proprietary Aquaporin Inside® technology, the company applies scientific principles from biology, chemistry, and physics to develop solutions for improving water quality and sustainability. They have garnered attention for their innovative approaches, evidenced by collaborations with high-profile partners including NASA.

As part of their strategic focus, Aquaporin plans to utilize the proceeds from this rights issue to bolster its operations and enhance its technological advancements aimed at water purification.

Conclusion

This announcement highlights a pivotal moment for Aquaporin A/S and its shareholders, emphasizing the importance of timely decision-making in navigating the rights issue effectively. As the last day of trading approaches, shareholders and investors are encouraged to review their positions thoroughly to maximize their rights in this significant undertaking.

For more detailed inquiries or information regarding the rights issue, investors are directed to the company's official website or to reach out to company executives directly.

This news is a reminder of the dynamic nature of investment opportunities and the importance of active participation in company's rights issues. All stakeholders should keep themselves informed and ready to act to ensure they do not miss out on significant corporate events like this.